These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8496990)

  • 1. Magnetic resonance imaging of the central nervous system in children with a new nonionic gadolinium contrast agent--gadoteridol injection (ProHance).
    Byrd SE; Darling CF; Wilczynski MA
    J Natl Med Assoc; 1993 May; 85(5):361-6. PubMed ID: 8496990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase III multicenter clinical investigation to determine the safety and efficacy of gadoteridol in children suspected of having neurologic disease.
    Ball WS; Nadel SN; Zimmerman RA; Byrd SE; Dietrich RB; Prenger EC; Drayer BP; Nelson MD; Morgan FW; Altman NR
    Radiology; 1993 Mar; 186(3):769-74. PubMed ID: 8430186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and diagnostic efficacy of gadoteridol for magnetic resonance imaging of the brain and spine in children 2 years of age and younger.
    Shah CC; Spampinato MV; Parmar HA; Raslan OA; Tomà P; Lin DDM; Vymazal J; Colosimo C; Enterline DS
    Pediatr Radiol; 2021 Sep; 51(10):1895-1906. PubMed ID: 33950270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase III clinical studies with gadoteridol for the evaluation of neurologic pathology. A European perspective.
    Seiderer M
    Invest Radiol; 1992 Aug; 27 Suppl 1():S33-8. PubMed ID: 1506151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of gadoteridol for contrast-enhanced magnetic resonance imaging in children.
    Ball WS; Parker JR; Davis PC; Glasier CM; Morris MR
    Invest Radiol; 1992 Aug; 27 Suppl 1():S45-52. PubMed ID: 1506153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast enhancement issues in the MR evaluation of the central nervous system.
    Colosimo C; Manfredi R; Tartaglione T
    Eur Radiol; 1997; 7 Suppl 5():231-7. PubMed ID: 9370549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase III clinical evaluation of gadoteridol injection: experience in pediatric neuro-oncologic MR imaging.
    Debatin JF; Nadel SN; Gray L; Friedman HS; Trotter P; Hockenberger B; Oakes WJ
    Pediatr Radiol; 1992; 22(2):93-8. PubMed ID: 1501959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical safety and efficacy of gadoteridol: a study in 411 patients with suspected intracranial and spinal disease.
    Runge VM; Bradley WG; Brant-Zawadzki MN; Carvlin MJ; DeSimone DN; Dean BL; Dillon WP; Drayer BP; Flanders AE; Harms SE
    Radiology; 1991 Dec; 181(3):701-9. PubMed ID: 1947085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II clinical trial of gadoteridol injection, a low-osmolal magnetic resonance imaging contrast agent.
    Carvlin MJ; De Simone DN; Meeks MJ
    Invest Radiol; 1992 Aug; 27 Suppl 1():S16-21. PubMed ID: 1506148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of gadoteridol for magnetic resonance imaging of the brain and spine.
    Runge VM; Bronen RA; Davis KR
    Invest Radiol; 1992 Aug; 27 Suppl 1():S22-32. PubMed ID: 1506150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of cerebral diseases: how much contrast agent is enough? Comparison of 0.1, 0.2, and 0.3 mmol/kg gadoteridol at 0.2 T with 0.1 mmol/kg gadoteridol at 1.5 T.
    Brekenfeld C; Foert E; Hundt W; Kenn W; Lodeann KP; Gehl HB
    Invest Radiol; 2001 May; 36(5):266-75. PubMed ID: 11323514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of the use of high-dose gadoteridol in the magnetic resonance evaluation of central nervous system tumors.
    Yuh WT; Fisher DJ; Mayr-Yuh NA; Tali ET; Nguyen HD; Gao F; Ehrhardt JC
    Invest Radiol; 1992 Aug; 27 Suppl 1():S39-44. PubMed ID: 1506152
    [No Abstract]   [Full Text] [Related]  

  • 13. Gadodiamide injection: nonionic gadolinium chelate for MR imaging of the brain and spine--phase II-III clinical trial.
    Greco A; McNamara MT; Lanthiez P; Quay SC; Michelozzi G
    Radiology; 1990 Aug; 176(2):451-6. PubMed ID: 2195593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of Omniscan (gadodiamide) in magnetic resonance studies of the central nervous system (results of a multicenter study)].
    Sinitsyn VE; Kornienko VN; Nikitin VG; Pronin IN; Ternovoĭ SK; Tiutin LA; Iakobson MG
    Vestn Rentgenol Radiol; 1995; (4):5-11. PubMed ID: 8571538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gadolinium-enhanced MR images of the growing piglet skeleton: ionic versus nonionic contrast agent.
    Menezes NM; Olear EA; Li X; Connolly SA; Zurakowski D; Foley M; Shapiro F; Jaramillo D
    Radiology; 2006 May; 239(2):406-14. PubMed ID: 16641351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gd DTPA: a review of clinical indications in central nervous system magnetic resonance imaging.
    Runge VM; Carollo BR; Wolf CR; Nelson KL; Gelblum DY
    Radiographics; 1989 Sep; 9(5):929-58. PubMed ID: 2678298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-resolution 3D-MRI of postmortem brain specimens fixed by formalin and gadoteridol.
    Kanawaku Y; Someya S; Kobayashi T; Hirakawa K; Shiotani S; Fukunaga T; Ohno Y; Kawakami S; Kanetake J
    Leg Med (Tokyo); 2014 Jul; 16(4):218-21. PubMed ID: 24709037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of cerebral perfusion by first-pass, dynamic, contrast-enhanced, steady-state free-precession MR imaging: an animal study.
    Runge VM; Kirsch JE; Wells JW; Woolfolk CE
    AJR Am J Roentgenol; 1993 Mar; 160(3):593-600. PubMed ID: 8430562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of gadoteridol for magnetic resonance imaging of extracranial head and neck pathology.
    Zoarski GH; Parker JR; Lufkin RB; Harnsberger HR; Rhoda CH
    Invest Radiol; 1992 Aug; 27 Suppl 1():S53-7. PubMed ID: 1506154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase III multicenter trial of high-dose gadoteridol in MR evaluation of brain metastases.
    Yuh WT; Fisher DJ; Runge VM; Atlas SW; Harms SE; Maravilla KR; Mayr NA; Mollman JE; Price AC
    AJNR Am J Neuroradiol; 1994 Jun; 15(6):1037-51. PubMed ID: 8073972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.